This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie Grant Agreement No. 956851.

Associate Prof. Alexandra Teleki

Alexandra Teleki is an Associate Professor and SciLifeLab Fellow in Pharmaceutical Nanotechnology and Drug Development at the Department of Pharmacy at Uppsala University, Sweden. She received her MSc in Chemical Engineering from the Royal Institute of Technology (KTH) Stockholm, Sweden and her PhD in Mechanical and Process Engineering from ETH Zurich, Switzerland. Then she joined the Formulation and Application R&D department at DSM Nutritional Products in Basel, Switzerland before she was recruited to Uppsala University and SciLifeLab. Her research has been recognized internationally by several awards including the 2020 ERC Consolidator Grant, 2016 Smoluchowski Award of the European Aerosol Association, the 2016 SABIC Young Professional Award by the Particle Technology Forum (PTF) of the American Institute of Chemical Engineers (AIChE), the 2009 DSM Science and Technology Awards for outstanding PhD work with a clear future impact and the 2008 ETH Medal for Outstanding PhD. She was also recently recognized by the editors of JPharmSci as an Outstanding Early Career Scientist. She is co-director of the Swedish Drug Delivery Center and serves as president of the Controlled Release Society Nordic Local Chapter since 2023.